Conformational Plasticity in Human Heme-Based Dioxygenases.
Khoa N PhamAriel Lewis-BallesterSyun-Ru YehPublished in: Journal of the American Chemical Society (2020)
Human indoleamine 2,3-dioxygenase 1 (hIDO1) and human tryptophan dioxygenase (hTDO) are two important heme proteins that degrade the essential amino acid, l-tryptophan (Trp), along the kynurenine pathway. The two enzymes share a similar active site structure and an analogous catalytic mechanism, but they exhibit a variety of distinct functional properties. Here we used carbon monoxide (CO) as a structural probe to interrogate how the functionalities of the two enzymes are encoded in their structures. With X-ray crystallography, we detected an unexpected photochemical intermediate trapped in a crystal of the hIDO1-CO-Trp complex, where CO is photolyzed from the heme iron by X-rays at cryogenic temperatures (100 K). The CO photolysis triggers a large-scale migration of the substrate Trp, as well as the photolyzed CO, from the active site to a temporary binding site, Sa*. It is accompanied by a large conformational change to an active site loop, JK-LoopC, despite the severely restricted protein motion under the frozen conditions, which highlights the remarkable conformational plasticity of the hIDO1 protein. Comparative studies of a crystal of the hTDO-CO-Trp complex show that CO and Trp remain bound in the active site under comparable X-ray illumination, indicating a much more rigid protein architecture. The data offer important new insights into the structure and function relationships of the heme-based dioxygenases and provide new guidelines for structure-based design of inhibitors targeting them.
Keyphrases
- amino acid
- endothelial cells
- molecular dynamics
- molecular dynamics simulations
- induced pluripotent stem cells
- high resolution
- pluripotent stem cells
- single molecule
- protein protein
- computed tomography
- transcription factor
- deep learning
- quantum dots
- electronic health record
- living cells
- artificial intelligence
- high speed
- cancer therapy
- crystal structure
- case control